Nicotine replacement therapy for smoking cessation
153 results
101 - 153
Individual behavioural counselling for smoking cessation- Interventions to reduce harm from continued tobacco use
- Smoking cessation for chronic obstructive pulmonary disease
- Factors influencing the uptake and use of nicotine replacement therapy and e‐cigarettes in pregnant women who smoke: a qualitative evidence synthesis
Combined pharmacotherapy and behavioural interventions for smoking cessation - Acupuncture and related interventions for smoking cessation: Cochrane systematic review
- Interventions for quitting vaping
Varenicline similar in effectiveness to nicotine patch- Interventions for preventing weight gain after smoking cessation
- Interventions for smokeless tobacco use cessation
- Smoking cessation in individuals with serious mental illness
- Relapse prevention interventions for smoking cessation
- Tobacco cessation interventions for young people
- Smoking cessation for people with chronic obstructive pulmonary disease
- Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
- Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders
- Antidepressants for smoking cessation
- Nicotine receptor partial agonists for smoking cessation
- Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases
- Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
- Interventions for smoking cessation in hospitalised patients
- Combined pharmacotherapy and behavioural interventions for smoking cessation
- Electronic cigarettes for smoking cessation
- Healthcare financing systems for increasing the use of tobacco dependence treatment
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Workplace interventions for smoking cessation
- Interventions for recruiting smokers into cessation programmes
- Print‐based self‐help interventions for smoking cessation
- Psychosocial interventions for smoking cessation in patients with coronary heart disease
- Differences in the effectiveness of individual‐level smoking cessation interventions by socioeconomic status
- Varenicline, bupropion may not increase risk of cardiovascular events
- Pharmacological interventions for smoking cessation: an overview and network meta‐analysis
- Community interventions for reducing smoking among adults: Cochrane systematic review
- Interventions for tobacco use cessation in people living with HIV
- Interventions to increase adherence to medications for tobacco dependence
- Smoking reduction interventions for smoking cessation
- Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke
- ACC/AHA guideline for the management of patients with chronic coronary disease
- Psychosocial interventions for supporting women to stop smoking in pregnancy
- Interventions for tobacco cessation delivered by dental professionals
- Antenatal clinics: care and examinations
- Palliative treatment